Cellzome Limited
Records under this name other than the patents Cellzome Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,835,482 | Novel Substituted Indazole and Aza-Indazole Derivatives as Gamma Secretase Modulators Lapsed on the fee record Ended Sep 16, 2026 · High confidence | Lapsed on the fee record | Ended Sep 16, 2026 | High confidence |
| US 8,772,504 | Novel Substituted Benzoxazole, Benzimidazole, Oxazolopyridine and Imidazopyridine Derivatives as Gamma Secretase Modulators Lapsed on the fee record Ended Jul 8, 2026 · High confidence | Lapsed on the fee record | Ended Jul 8, 2026 | High confidence |
| US 8,546,440 | Substituted bicyclic imidazole derivatives as gamma secretase modulators Lapsed on the fee record Ended Oct 1, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 1, 2025 | From the USPTO record |
| US 9,655,897 | Heterocyclyl pyrimidine analogues as TYK2 inhibitors Lapsed on the fee record Ended May 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 23, 2025 | From the USPTO record |
| US 9,296,725 | Heterocyclyl pyrimidine analogues as TYK2 inhibitors Lapsed on the fee record Ended Mar 29, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 29, 2024 | From the USPTO record |
| US 9,242,993 | Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mTOR inhibitors Lapsed on the fee record Ended Jan 26, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 26, 2024 | From the USPTO record |
| US 9,175,011 | Morpholino substituted urea or carbamate derivatives as MTOR inhibitors Lapsed on the fee record Ended Nov 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 3, 2023 | From the USPTO record |
| US 9,115,143 | Novel Substituted Indole Derivatives as Gamma Secretase Modulators Formerly held Lapsed on the fee record Ended Aug 25, 2023 · High confidence | Lapsed on the fee record | Ended Aug 25, 2023 | High confidence |
| US 9,079,886 | Novel Substituted Triazole Derivatives as Gamma Secretase Modulators Lapsed on the fee record Ended Jul 14, 2023 · High confidence | Lapsed on the fee record | Ended Jul 14, 2023 | High confidence |
| US 8,946,266 | Novel Substituted Triazole and Imidazole Derivatives as Gamma Secretase Modulators Lapsed on the fee record Ended Feb 3, 2023 · High confidence | Lapsed on the fee record | Ended Feb 3, 2023 | High confidence |